2011 Energy Operations Pharmaceuticals 
Harvard Business Review
MAY 20, 2014
The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers. Consolidation of the financial sector has led to similar dynamics in other industries.
Harvard Business Review
FEBRUARY 24, 2015
The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
JUNE 16, 2016
The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011. The Joint Center For Energy Storage Research (JCESR) has a five-year mandate to develop next generation battery technologies. “But here, we can operate within the time frame of the next coffee break.” The Era of Big Science.
Harvard Business Review
SEPTEMBER 14, 2011
We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. In 2008, Dr Reddy's acquired Chirotech, Dow Chemical's R&D unit, for $32 million, and in April 2011 relocated it to a new 33,000 sq. You can't run your global R&D operations from headquarters in Mumbai. Cambridge, U.K.
Strategy Driven
JANUARY 24, 2011
Plus, as a result of a lack of cross-organizational coordination and cooperation, Nokia wasn’t able to improve its proprietary operating system, Symbian, which would have allowed it to support a more sophisticated smartphone. Here are a few of this year’s headline makers and the lessons that can be learned from each of them.
Expert insights. Personalized for you.
11 
Let's personalize your content